CURASEN Trademark

Trademark Overview

On Monday, July 27, 2020, a trademark application was filed for CURASEN with the United States Patent and Trademark Office. The USPTO has given the CURASEN trademark a serial number of 90075978. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Monday, April 1, 2024. This trademark is owned by Curasen Therapeutics, Inc.. The CURASEN trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products for the prevention, treatment and diagnosis of neurological diseases, namely, Parkinson's disease

Scientific research for medical purposes in the areas of neurological, immunological, cardiovascular, respiratory, and orphan diseases, excluding dermatological, dental, orthopedic and blood-based diseases
curasen

General Information

Serial Number90075978
Word MarkCURASEN
Filing DateMonday, July 27, 2020
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 10, 2021

Trademark Statements

Goods and ServicesPharmaceutical products for the prevention, treatment and diagnosis of neurological diseases, namely, Parkinson's disease
Goods and ServicesScientific research for medical purposes in the areas of neurological, immunological, cardiovascular, respiratory, and orphan diseases, excluding dermatological, dental, orthopedic and blood-based diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 25, 2020
Primary Code005
First Use Anywhere DateMonday, December 31, 2018
First Use In Commerce DateSunday, October 31, 2021
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 25, 2020
Primary Code042
First Use Anywhere DateMonday, December 31, 2018
First Use In Commerce DateSunday, October 31, 2021

Trademark Owner History

Party NameCurasen Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Carlos, CA 94070
Party NameCurasen Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Mateo, CA 94403

Trademark Events

Event DateEvent Description
Thursday, July 30, 2020NEW APPLICATION ENTERED
Tuesday, August 25, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 12, 2020ASSIGNED TO EXAMINER
Monday, November 16, 2020NON-FINAL ACTION WRITTEN
Monday, November 16, 2020NON-FINAL ACTION E-MAILED
Monday, November 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 17, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 17, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 18, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 16, 2021EXAMINERS AMENDMENT -WRITTEN
Wednesday, June 16, 2021EXAMINERS AMENDMENT E-MAILED
Wednesday, June 16, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, June 16, 2021EXAMINER'S AMENDMENT ENTERED
Thursday, July 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 21, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 10, 2021PUBLISHED FOR OPPOSITION
Tuesday, August 10, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 5, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, March 14, 2022SOU TEAS EXTENSION RECEIVED
Monday, March 14, 2022SOU EXTENSION 1 FILED
Monday, March 14, 2022SOU EXTENSION 1 GRANTED
Wednesday, March 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 3, 2022SOU TEAS EXTENSION RECEIVED
Monday, October 3, 2022SOU EXTENSION 2 FILED
Monday, October 3, 2022SOU EXTENSION 2 GRANTED
Wednesday, October 5, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 5, 2023SOU EXTENSION 3 FILED
Monday, May 8, 2023ABANDONMENT - NO USE STATEMENT FILED
Monday, May 8, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 26, 2023TEAS PETITION TO REVIVE RECEIVED
Monday, June 26, 2023PETITION TO REVIVE-GRANTED
Monday, June 26, 2023SOU EXTENSION RECEIVED WITH TEAS PETITION
Monday, June 26, 2023NOTICE OF REVIVAL - E-MAILED
Monday, August 7, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 9, 2023SOU EXTENSION 3 GRANTED
Thursday, August 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 27, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, September 27, 2023SOU EXTENSION 4 FILED
Wednesday, September 27, 2023SOU EXTENSION 4 GRANTED
Friday, September 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 29, 2024USE AMENDMENT FILED
Friday, March 29, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 29, 2024SOU EXTENSION 5 FILED
Friday, March 29, 2024SOU EXTENSION 5 GRANTED
Friday, March 29, 2024TEAS STATEMENT OF USE RECEIVED
Saturday, March 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 1, 2024STATEMENT OF USE PROCESSING COMPLETE
Saturday, June 29, 2024TEAS REQUEST TO DIVIDE RECEIVED
Saturday, June 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 1, 2024SU - NON-FINAL ACTION - WRITTEN
Monday, April 1, 2024NON-FINAL ACTION E-MAILED
Monday, April 1, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

curasen diseases neurological orphan respiratory cardiovascular immunological excluding areas blood orthopedic